Product Description
| Cat Number | PP-150 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Optimised variation of CBD3 |
| Modification | None |
| Purity | >95% by HPLC |
| Biomarker Target | Protein-protein interactions,Calcium channels |
| Sequence Three Letter Code | H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Ala-Arg-Ser-Arg-Leu-Lys-Glu-Leu-Arg-Gly-Val-Pro-Arg-Gly-Leu-OH |
| Molecular Formula | C137H250N60O32 |
| Sl Sequence | YGRKKRRQRRRARSRLKELRGVPRGL |
| Solubility | Soluble in DMSO |
| Appearance | Freeze dried solid |
| Storage | Store desiccated, frozen and in the dark |
| References |
Piekarz et al (2012) CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy. Mol. Pain 8 54 PMID: 22828369 Related areas_x000D_ All cell penetrating peptides >All protein-protein interaction modulators >All calcium channel modulators >All pain research categories > |
| Note | The product is for research use only |
Share Item: